Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2023-03-13 00:00:00 ET · period of report 2023-03-11 · accession 0001055726-23-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-13	2023-03-13	INO	Weiner David B.	Dir	S - Sale+OE	$1.15	-5,833	910.1K	-0.6%	-$6,708
D	2023-03-13	2023-03-11	INO	Weiner David B.	Dir	M - OptEx	—	+11.7K	916.0K	+1%	—
D	2023-03-13	2023-03-11	INO	Weiner David B.	Dir	M - OptEx	$0.00	-11.7K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-13	S	D	5,833	$1.15	910,124	D	—	—
2	Common	Common Stock	2023-03-11	M	A	11,666	—	915,957	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
3	Derivative	Restricted Stock Unit	2023-03-11	M	D	11,666	$0.00	0	D	— · — to —	11,666 Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.